The E-cigarette Industry Is Unhappy With The FDA

近日，美国食品药品监督管理局（FDA）宣布，计划调整烟草产品中心（CTP）。然而，电子烟行业代表对该计划表示不满。 CTP饱受各方抨击，控烟人士呼吁该机构加强对卷烟和调味电子烟的监管，烟草公司则抱怨FDA不愿批准电子烟等新产品上市。为此，FDA承诺重新调整该机构。 CTP负责人承诺，将在2023年年底之前制定一项五年计划，列出优先事项，包括重点清理大量未经授权上市的电子烟，同时提高决策透明度。美国电子烟制造商协会认为，FDA提出所谓的“五年计划”是推卸责任、拖延时间的托辞。 Recently, the US Food and Drug Administration (FDA) announced plans to restructure the Center for Tobacco Products (CTP). However, e-cigarette industry representatives complained about the plan. The CTPS have come under fire from all sides, with tobacco control advocates calling on the agency to tighten oversight of cigarettes and flavored e-cigarettes, and tobacco companies complaining that the FDA is reluctant to approve new products like e-cigarettes. To that end, the FDA promised to realign the agency. The head of the CTP promised a five-year plan outlining priorities by the end of 2023, including a focus on cleaning up the large number of unauthorised e-cigarettes on the market and making decisions more transparent. The e-cigarette Manufacturers Association says the FDA's so-called five-year plan is an excuse to pass the buck and buy time.